EICHOR
● Completed
A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus · Sponsor: Lakefront Biotherapeutics NV
About this study
A study evaluating the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GLPG3667 administered orally once daily for 48 weeks in approximately 180 adult participants with active Systemic Lupus Erythematosus (SLE).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (84)
| University of Arizona College of Medicine - Tucson | Tucson, Arizona, United States | — |
| University of California San Diego | La Jolla, California, United States | — |
| Desert Medical Advances | Rancho Mirage, California, United States | — |
| Millennium Clinical Trials | Simi Valley, California, United States | — |
| Inland Rheumatology Clinical Trials | Upland, California, United States | — |
| Upland Rheumatology Center | Upland, California, United States | — |
| Arthritis & Rheumatic Disease Specialties | Aventura, Florida, United States | — |
| Omega Research DeBary | DeBary, Florida, United States | — |
| Alloy Clinical Research, LLC | Kissimmee, Florida, United States | — |
| San Marcus Research Clinic | Miami, Florida, United States | — |
| Advanced Pharma - Miami | Miami, Florida, United States | — |
| Professional Research Center | Miami, Florida, United States | — |
+ 72 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05856448